Sleep Disorder Connect
  • Saved

1yr
REM Sleep Behavior Disorder and Cognitive Functions in Parkinson's Patients: A Systematic Review - PubMed

REM Sleep Behavior Disorder and Cognitive Functions in Parkinson's Patients: A Systematic Review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38068449/

Sleep disorders, such as REM sleep behavior disorder (RBD) and excessive daytime sleepiness, are among the most common non-motor symptoms in subjects with Parkinson's disease (PD). Sleep disorders have a...

Sleep disorders, particularly REM sleep behavior disorder (RBD) in Parkinson's disease (PD), impair cognitive functions, predict dementia risk, and significantly impact patient and caregiver quality of life.

  • Saved

1yr
Exploring Advances in Psychopharmacology at the NEI Annual Conference

In this video, Dr. David Goodman, an NEI faculty member and Johns Hopkins expert, explores the latest advancements in psychopharmacology presented at the 2024 NEI Annual Conference. Key highlights include the emerging role of GLP-1 receptor agonists in managing diabetes and their potential to address brain inflammation. Dr. Goodman also discusses innovative treatments for ADHD and Alzheimer’s, as well as groundbreaking research into intracellular processes like mTOR pathway modulation. These insights equip physicians with actionable strategies to enhance the precision and efficacy of neurological and psychiatric care.

  • Saved

1yr

Did you know? In Rhode Island, integrated behavioral health interventions led to a significant reduction in health care utilization. Emergency department visits dropped by 6.4 per 1,000 people per month, and office visits decreased by 29.8 per 1,000 people per month, reflecting a 7% and 6% reduction, respectively. This highlights the positive impact of behavioral health integration on overall health care demand.

How can expanding integrated behavioral health programs further reduce health care utilization and improve patient outcomes across communities?

background

How can expanding integrated behavioral health programs further reduce health care utilization and improve patient outcomes across communities?

  • Saved

1yr
Review of Opsoclonus-Myoclonus Ataxia Syndrome in Pediatric Patients - PubMed

Review of Opsoclonus-Myoclonus Ataxia Syndrome in Pediatric Patients - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38539402/

Opsoclonus-myoclonus ataxia syndrome (OMAS), also known as Kinsbourne syndrome, is a rare disorder that presents with myoclonus, ataxia, abnormal eye movements, irritability, and sleep disruptions, often in young children. We...

This case report describes a 6-month-old infant diagnosed with opsoclonus-myoclonus ataxia syndrome (OMAS) due to neuroblastoma, treated with surgery, steroids, IVIG, and rituximab, with mild developmental delays post-treatment.

  • Saved

1yr
Respiratory involvement and sleep-related disorders in CMT1A: case report and review of the literature - PubMed

Respiratory involvement and sleep-related disorders in CMT1A: case report and review of the literature - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38229594/

Sleep-disordered breathing has been reported in Charcot-Marie-Tooth disease (CMT) type 1A in association with diaphragmatic weakness and sleep apnea syndrome, mainly of the obstructive type (OSA). Improvement has been observed...

In Charcot-Marie-Tooth disease type 1A, sleep-disordered breathing linked to diaphragmatic weakness can improve with nocturnal ventilation, highlighting the need for routine assessment of respiratory symptoms to enhance patient care.